Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Molecular clustering on ctDNA improves the prognostic stratification of DLBCL patients compared to ctDNA levels.
Moia R, Talotta D, Terzi di Bergamo L, Almasri M, Dondolin R, Salehi M, Cosentino C, Soscia R, Della Starza I, Bruscaggin A, Andorno AG, Mercalli F, Cresta S, Bomben R, Bittolo T, Vit F, Bulian P, Zucchetto A, Bruna R, Rivolta GM, Schipani M, Secomandi E, Kogila S, Bellia M, Mouhssine S, Nabki J, Al Deeban B, Ghanej J, Cividini L, Maher N, Melle F, Motta G, Leutner M, Lorenzi A, Mahmoud AM, Al Essa W, Deambrog C, Rasi S, Petrucci L, Boldorini R, Di Rocco A, Del Giudice I, Spina M, Palazzolo S, Canal F, Canzonieri V, Martelli M, Pileri SA Professor, Gattei V, Foà R, Rossi D, Gaidano G. Moia R, et al. Among authors: mouhssine s. Blood Adv. 2025 Jan 18:bloodadvances.2024014136. doi: 10.1182/bloodadvances.2024014136. Online ahead of print. Blood Adv. 2025. PMID: 39825831
Immunoglobulin light chain mutational status refines IGHV prognostic value in identifying chronic lymphocytic leukemia patients with early treatment requirement.
Nabki J, Al Deeban B, Sium AM, Cosentino C, Almasri M, Awikeh B, Maher N, Bellia M, Dondolin R, Mouhssine S, Talotta D, Secomandi E, Kogila S, Ghanej J, Maiellaro F, Cividini L, Rasi S, Chiarenza A, Olivieri J, Gentile M, Zaja F, Del Principe MI, Laurenti L, Bomben R, Vit F, Bittolo T, Zucchetto A, Gattei V, Gaidano G, Moia R. Nabki J, et al. Among authors: mouhssine s. Leukemia. 2024 Dec 17. doi: 10.1038/s41375-024-02499-x. Online ahead of print. Leukemia. 2024. PMID: 39690182
Current Therapeutic Sequencing in Chronic Lymphocytic Leukemia.
Mouhssine S, Maher N, Kogila S, Cerchione C, Martinelli G, Gaidano G. Mouhssine S, et al. Hematol Rep. 2024 Apr 30;16(2):270-282. doi: 10.3390/hematolrep16020027. Hematol Rep. 2024. PMID: 38804280 Free PMC article. Review.
XPO1 mutations identify early-stage CLL characterized by shorter time to first treatment and enhanced BCR signalling.
Moia R, Terzi di Bergamo L, Talotta D, Bomben R, Forestieri G, Spina V, Bruscaggin A, Cosentino C, Almasri M, Dondolin R, Bittolo T, Zucchetto A, Baldoni S, Del Giudice I, Mauro FR, Maffei R, Chiarenza A, Tafuri A, Laureana R, Del Principe MI, Zaja F, D'Arena G, Olivieri J, Rasi S, Mahmoud A, Al Essa W, Awikeh B, Kogila S, Bellia M, Mouhssine S, Sportoletti P, Marasca R, Scarfò L, Ghia P, Gattei V, Foà R, Rossi D, Gaidano G. Moia R, et al. Among authors: mouhssine s. Br J Haematol. 2023 Nov;203(3):416-425. doi: 10.1111/bjh.19052. Epub 2023 Aug 14. Br J Haematol. 2023. PMID: 37580908
Long-term benefit of IGHV mutated patients in a real-life multicenter cohort of FCR-treated chronic lymphocytic leukemia.
Moia R, Dondolin R, De Propris MS, Talotta D, Mouhssine S, Perutelli F, Reda G, Mattiello V, Rigolin GM, Motta M, Olivieri J, Fanin R, Perbellini O, Ferrarini I, Mauro FR, Del Giudice I, Laurenti L, Tomasso A, Gentile M, Frustaci AM, Tedeschi A, Gozzetti A, Stelitano C, Visco C, Moreno C, Forconi F, Marasca R, Coscia M, Rossi D, Foà R, Gaidano G. Moia R, et al. Among authors: mouhssine s. Hematol Oncol. 2023 Aug;41(3):567-570. doi: 10.1002/hon.3080. Epub 2022 Oct 10. Hematol Oncol. 2023. PMID: 36190298 No abstract available.
13 results